tetano
Editor, Senior Moderator
Emerg Infect Dis
. 2020 Aug 3;26(12).
doi: 10.3201/eid2612.201664. Online ahead of print.
Small Particle Aerosol Exposure of African Green Monkeys to MERS-CoV as a Model for Highly Pathogenic Coronavirus Infection
Allison Totura, Virginia Livingston, Ondraya Frick, David Dyer, Donald Nichols, Aysegul Nalca
Abstract
Emerging coronaviruses are a global public health threat because of the potential for person-to-person transmission and high mortality rates. Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in 2012, causing lethal respiratory disease in ?35% of cases. Primate models of coronavirus disease are needed to support development of therapeutics, but few models exist that recapitulate severe disease. For initial development of a MERS-CoV primate model, 12 African green monkeys were exposed to 10[SUP]3[/SUP], 10[SUP]4[/SUP], or 10[SUP]5[/SUP] PFU target doses of aerosolized MERS-CoV. We observed a dose-dependent increase of respiratory disease signs, although all 12 monkeys survived for the 28-day duration of the study. This study describes dose-dependent effects of MERS-CoV infection of primates and uses a route of infection with potential relevance to MERS-CoV transmission. Aerosol exposure of African green monkeys might provide a platform approach for the development of primate models of novel coronavirus diseases.
Keywords: COVID-19; MERS; MERS-CoV; Middle East respiratory syndrome; SARS-CoV; SARS-CoV-2; coronavirus disease; medical countermeasures; model; primate; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.
. 2020 Aug 3;26(12).
doi: 10.3201/eid2612.201664. Online ahead of print.
Small Particle Aerosol Exposure of African Green Monkeys to MERS-CoV as a Model for Highly Pathogenic Coronavirus Infection
Allison Totura, Virginia Livingston, Ondraya Frick, David Dyer, Donald Nichols, Aysegul Nalca
- PMID: 32744989
- DOI: 10.3201/eid2612.201664
Abstract
Emerging coronaviruses are a global public health threat because of the potential for person-to-person transmission and high mortality rates. Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in 2012, causing lethal respiratory disease in ?35% of cases. Primate models of coronavirus disease are needed to support development of therapeutics, but few models exist that recapitulate severe disease. For initial development of a MERS-CoV primate model, 12 African green monkeys were exposed to 10[SUP]3[/SUP], 10[SUP]4[/SUP], or 10[SUP]5[/SUP] PFU target doses of aerosolized MERS-CoV. We observed a dose-dependent increase of respiratory disease signs, although all 12 monkeys survived for the 28-day duration of the study. This study describes dose-dependent effects of MERS-CoV infection of primates and uses a route of infection with potential relevance to MERS-CoV transmission. Aerosol exposure of African green monkeys might provide a platform approach for the development of primate models of novel coronavirus diseases.
Keywords: COVID-19; MERS; MERS-CoV; Middle East respiratory syndrome; SARS-CoV; SARS-CoV-2; coronavirus disease; medical countermeasures; model; primate; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.